20 September 2023: Clinical Research
Early Echocardiography and ECG Changes Following Radiotherapy in Patients with Stage II–III HER2-Positive Breast Cancer Treated with Anthracycline-Based Chemotherapy with or without Trastuzumab-Based Therapy
Radu Valeriu Toma 12ABCG , Zgura Anca 1E , Oana Gabriela Trifănescu 12A , Laurenţia Nicoleta Galeş 12D* , Antonia Ruxandra Folea 2CDEF , Loredana Stanca 3B , Liviu Bîlteanu 234ABCDEF* , Rodica M. Anghel 1ADOI: 10.12659/MSM.941754
Med Sci Monit 2023; 29:e941754
Supplementary Table 6 Descriptive statistics for the four cycles doses of anthracyclines delivered to some of the patients in the study group.
| Cycle 1 dose | Cycle 2 dose | Cycle 3 dose | Cycle 4 dose | ||
|---|---|---|---|---|---|
| N | 57 | 57 | 54 | 49 | |
| Mean | 132.63 | 145.54 | 148.59 | 154.86 | |
| Std. error of mean | 3.32 | 3.52 | 3.28 | 2.98 | |
| Std. deviation | 24.85 | 26.31 | 24.13 | 20.84 | |
| Variance | 617.51 | 692.43 | 582.32 | 434.12 | |
| Range | 140 | 140 | 96 | 98 | |
| Minimum | 50 | 50 | 90 | 90 | |
| Maximum | 190 | 190 | 186 | 188 | |
| Percentiles | 25 | 120.00 | 135.00 | 135.00 | 140.00 |
| 33 | 124.05 | 140.00 | 140.00 | 145.00 | |
| 50 | 135.00 | 150.00 | 150.00 | 160.00 | |
| 67 | 140.95 | 160.00 | 160.00 | 167.50 | |
| 75 | 150.00 | 160.00 | 170.00 | 170.00 | |